Last reviewed: June 10, 2026
Last updated: June 10, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that signals your brain to reduce hunger and slow stomach emptying, leading to meaningful weight loss for many patients. Clinical trials show participants using semaglutide lose approximately 15% of their body weight over 68 weeks. PlexusDx delivers compounded semaglutide injections through licensed 503A pharmacies, making this therapy accessible without insurance.
How Semaglutide Injections Reduce Appetite and Body Weight
Semaglutide works by binding to GLP-1 receptors in your brain's appetite-control centers, triggering feelings of fullness with smaller meal portions. This mechanism also slows the rate food moves from your stomach into your intestines, which extends satiety between meals. Additionally, semaglutide improves how your body handles blood glucose, reducing energy crashes that often trigger overeating.
The medication takes effect within hours of injection, with most patients noticing reduced hunger by day two or three of treatment. Weight loss typically begins within the first two weeks, though the most significant changes occur over months three through six. Your body continues responding to semaglutide as long as you remain on treatment, with results stabilizing after about four months.
Clinical Evidence: What Research Shows About Semaglutide Efficacy
The STEP trials, which enrolled over 4,500 participants, demonstrated that semaglutide 2.4 mg once weekly produced an average weight loss of 15.3% of baseline body weight compared to 2.6% in the placebo group. Participants also experienced improvements in blood pressure, cholesterol levels, and blood sugar control independent of weight loss alone. These findings held true across diverse age groups, ethnic backgrounds, and baseline weight categories.
Notably, weight loss with semaglutide is not temporary—studies tracking patients for up to two years show sustained results as long as the medication continues. When people stop taking semaglutide, weight gradually returns, emphasizing that the medication works best as part of a longer-term health plan combined with lifestyle modifications. PlexusDx patients benefit from ongoing medical supervision to optimize dosing and monitor progress throughout their weight loss journey.
Semaglutide Injection Administration and Dosing Strategy
PlexusDx semaglutide injections are self-administered once weekly using a small needle, with injections taking less than 30 seconds. Most patients choose to inject on the same day each week for consistency, and the medication can be injected into the abdomen, thigh, or upper arm. Your PlexusDx provider determines your starting dose and creates a personalized escalation plan based on your tolerance and response.
The dosing approach begins at a lower amount to minimize side effects, then increases gradually every four weeks as your body adapts. Your dose may need to go up—your price won't, because PlexusDx charges a flat monthly rate regardless of dose level. This transparent pricing model means you never face surprise increases as your treatment progresses, making long-term weight loss management financially predictable.
Managing Side Effects and Optimizing Your Semaglutide Experience
Nausea is the most commonly reported side effect during the first few weeks, affecting approximately 25% of patients, though it typically resolves within 5–7 days as your body adjusts. Other temporary effects include mild constipation or fatigue, which can be managed through hydration, dietary fiber, and gradual dose increases. Taking your injection at night or with food sometimes reduces nausea, and PlexusDx providers can adjust your escalation schedule if side effects persist.
Serious side effects are rare but include pancreatitis (severe abdominal pain) and severe allergic reactions, which require immediate medical attention. Semaglutide is not recommended for people with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2. PlexusDx conducts a thorough medical evaluation before starting treatment to ensure semaglutide is safe for your individual health profile.
PlexusDx Precision Peptide Genetic Testing for Personalized GLP-1 Response
Your genetic makeup influences how effectively your body responds to GLP-1 medications like semaglutide. PlexusDx offers the Precision Peptide Genetic Test, which analyzes 14 metabolic pathways and 49 peptide-related genes to reveal how your body processes appetite-regulating hormones. Key variants such as GLP1R rs6923761 and GIPR rs1800437 directly affect receptor sensitivity and medication responsiveness.
Understanding your genetic profile helps PlexusDx providers customize your semaglutide protocol for maximum effectiveness, predicting whether you may benefit more from a rapid or gradual dose escalation. The test costs $99 as an add-on after your first month of treatment, providing insights that guide long-term therapy decisions. This personalized approach helps you achieve weight loss results faster while minimizing unnecessary dose adjustments and side effects.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How much weight can I expect to lose with semaglutide injections?
Most PlexusDx patients lose 10–20% of their starting body weight within six months, though results vary based on baseline weight, genetics, and lifestyle habits. Clinical trials show an average loss of 15.3% of body weight, with some patients losing even more through consistent effort. Your Precision Peptide Genetic Test can help predict your individual response trajectory.
How quickly does semaglutide start working for appetite suppression?
Many patients notice reduced hunger within 24–48 hours of their first injection, though peak appetite suppression builds over the first two weeks as your dose increases. Weight loss typically becomes visible by week two or three, with the most dramatic changes occurring between months two and four. Individual timing varies, so PlexusDx tracks your progress at regular intervals to ensure your dose is optimized.
What is the cost of semaglutide injections at PlexusDx?
PlexusDx semaglutide injections start at $149 per month with three commitment tier options available. Your dose may need to go up—your price won't, meaning you pay the same flat monthly rate regardless of dose escalation. The medication is HSA/FSA eligible, no insurance required, and available in all 50 states.
What are the most common side effects of semaglutide, and how long do they last?
Nausea affects about 25% of patients during the first 1–2 weeks, typically resolving as your body adapts; mild constipation and fatigue are also common early effects. Most side effects resolve within 5–7 days, especially if your dose escalates gradually as PlexusDx providers recommend. Serious side effects like pancreatitis are rare, and PlexusDx conducts thorough screening to ensure you are a safe candidate before starting treatment.
Will the Precision Peptide Genetic Test tell me if semaglutide is right for me?
The Precision Peptide Genetic Test analyzes variants in GLP1R and GIPR genes to predict how sensitively your body responds to GLP-1 medications, helping PlexusDx customize your protocol. The test maps 14 pathways and 150+ genetic insights across 49 peptides, revealing predispositions that guide dosing strategy and medication selection. At $99 as a month-two add-on, it enhances your personalized treatment plan for faster, more sustainable results.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Weight Loss: Can You Take Semaglutide After Gastric Bypass?
Can Ozempic Help With Migraines? New Research and Insights